These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 8978757

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. L-deprenyl protects mesencephalic dopamine neurons from glutamate receptor-mediated toxicity in vitro.
    Mytilineou C, Radcliffe P, Leonardi EK, Werner P, Olanow CW.
    J Neurochem; 1997 Jan; 68(1):33-9. PubMed ID: 8978707
    [Abstract] [Full Text] [Related]

  • 3. Deprenyl and desmethylselegiline protect mesencephalic neurons from toxicity induced by glutathione depletion.
    Mytilineou C, Leonardi EK, Radcliffe P, Heinonen EH, Han SK, Werner P, Cohen G, Olanow CW.
    J Pharmacol Exp Ther; 1998 Feb; 284(2):700-6. PubMed ID: 9454817
    [Abstract] [Full Text] [Related]

  • 4. L-deprenyl fails to protect mesencephalic dopamine neurons and PC12 cells from the neurotoxic effect of 1-methyl-4-phenylpyridinium ion.
    Vaglini F, Pardini C, Cavalletti M, Maggio R, Corsini GU.
    Brain Res; 1996 Nov 25; 741(1-2):68-74. PubMed ID: 9001706
    [Abstract] [Full Text] [Related]

  • 5. Deprenyl rescues dopaminergic neurons in organotypic slice cultures of neonatal rat mesencephalon from N-methyl-D-aspartate toxicity.
    Shimazu S, Katsuki H, Akaike A.
    Eur J Pharmacol; 1999 Jul 14; 377(1):29-34. PubMed ID: 10448922
    [Abstract] [Full Text] [Related]

  • 6. Increased survival of dopaminergic neurons by rasagiline, a monoamine oxidase B inhibitor.
    Finberg JP, Takeshima T, Johnston JM, Commissiong JW.
    Neuroreport; 1998 Mar 09; 9(4):703-7. PubMed ID: 9559942
    [Abstract] [Full Text] [Related]

  • 7. The multiple actions of selegiline.
    Ebadi M, Sharma S, Shavali S, Sangchot P, Brekke L.
    Proc West Pharmacol Soc; 2002 Mar 09; 45():39-41. PubMed ID: 12434521
    [No Abstract] [Full Text] [Related]

  • 8. Effect of MAO-B inhibitors on MPP+ toxicity in Vivo.
    Wu RM, Chen RC, Chiueh CC.
    Ann N Y Acad Sci; 2000 Mar 09; 899():255-61. PubMed ID: 10863544
    [Abstract] [Full Text] [Related]

  • 9. Desmethylselegiline, a metabolite of selegiline, is an irreversible inhibitor of monoamine oxidase type B in humans.
    Heinonen EH, Anttila MI, Karnani HL, Nyman LM, Vuorinen JA, Pyykkö KA, Lammintausta RA.
    J Clin Pharmacol; 1997 Jul 09; 37(7):602-9. PubMed ID: 9243353
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline.
    Kupsch A, Sautter J, Götz ME, Breithaupt W, Schwarz J, Youdim MB, Riederer P, Gerlach M, Oertel WH.
    J Neural Transm (Vienna); 2001 Jul 09; 108(8-9):985-1009. PubMed ID: 11716151
    [Abstract] [Full Text] [Related]

  • 13. Selegiline protects dopaminergic neurons in culture from toxic factor(s) present in the cerebrospinal fluid of patients with Parkinson's disease.
    Hao R, Ebadi M, Pfeiffer RF.
    Neurosci Lett; 1995 Nov 17; 200(2):77-80. PubMed ID: 8614567
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Neuroprotective actions of selegiline.
    Ebadi M, Sharma S, Shavali S, El Refaey H.
    J Neurosci Res; 2002 Feb 01; 67(3):285-9. PubMed ID: 11813232
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. D-deprenyl protects nigrostriatal neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity.
    Muralikrishnan D, Samantaray S, Mohanakumar KP.
    Synapse; 2003 Oct 01; 50(1):7-13. PubMed ID: 12872288
    [Abstract] [Full Text] [Related]

  • 18. Selegiline normalizes, while l-DOPA sustains the increased number of dopamine neurons in the olfactory bulb in a 6-OHDA mouse model of Parkinson's disease.
    Chiu WH, Carlsson T, Depboylu C, Höglinger GU, Oertel WH, Ries V.
    Neuropharmacology; 2014 Apr 01; 79():212-21. PubMed ID: 24291466
    [Abstract] [Full Text] [Related]

  • 19. Deprenyl (selegiline), a selective MAO-B inhibitor with active metabolites; effects on locomotor activity, dopaminergic neurotransmission and firing rate of nigral dopamine neurons.
    Engberg G, Elebring T, Nissbrandt H.
    J Pharmacol Exp Ther; 1991 Nov 01; 259(2):841-7. PubMed ID: 1658311
    [Abstract] [Full Text] [Related]

  • 20. L-deprenyl (selegiline) decreases excitatory synaptic transmission in the rat hippocampus via a dopaminergic mechanism.
    Hsu KS, Huang CC, Su MT, Tsai JJ.
    J Pharmacol Exp Ther; 1996 Nov 01; 279(2):740-7. PubMed ID: 8930179
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.